VASCULAR SOLUTIONS INC·4

Feb 1, 4:54 PM ET

VASCULAR SOLUTIONS INC 4

4 · VASCULAR SOLUTIONS INC · Filed Feb 1, 2005

Insider Transaction Report

Form 4
Period: 2005-01-28
NAGEL MICHAEL
VP of Worldwide Sales
Transactions
  • Award

    Stock Option (Right to Buy)

    2005-01-28$9.46/sh+25,000$236,500230,000 total
    Exercise: $9.46Exp: 2015-01-28Common Stock (25,000 underlying)
Holdings
  • Common Stock

    43,943
  • Stock Option (Right to Buy)

    Exercise: $1.50Exp: 2007-06-02Common Stock (45,000 underlying)
    45,000
  • Stock Option (Right to Buy)

    Exercise: $2.51Exp: 2011-10-19Common Stock (20,000 underlying)
    65,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (10,000 underlying)
    75,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (25,000 underlying)
    100,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (15,000 underlying)
    115,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (20,000 underlying)
    135,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (20,000 underlying)
    155,000
  • Stock Option (Right to Buy)

    Exercise: $0.84Exp: 2013-02-18Common Stock (25,000 underlying)
    180,000
  • Stock Option (Right to Buy)

    Exercise: $6.74Exp: 2014-01-27Common Stock (25,000 underlying)
    205,000
Footnotes (5)
  • [F1]100% fully vested.
  • [F2]26% on 10/19/02, 2% monthly thereafter.
  • [F3]26% on 2/18/04 and 2% on the 18th of each succeeding month thereafter.
  • [F4]26% on 1/27/05 and 2% on the 27th of each succeeding month thereafter.
  • [F5]26% on 1/28/06 and 2% on the 28th of each succeeding month thereafter.

Documents

1 file
  • 4
    vasc050422nagel_4ex.xmlPrimary